BUSINESS● LOW2h ago · Sep 15, 2026, 5:33 PM
Cellectis falls as Citizens downgrades on pivot to genetic medicines
Seeking Alpha Tech · global
Cellectis stock has declined after Citizens downgraded its rating due to the company's shift towards genetic medicines. This reflects investor reaction to a company's strategic change and analyst assessment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoPromiseland ends Tonto Dikeh’s ambassadorial dealVanguard NigeriaBUSINESS37m agoHot money or structural shift? Inside the emerging market debt surgeSeeking Alpha Tech